Biolase OverviewBiolase EBIT
EBIT (Earnings Before Interest and Taxes) analysis for BIOL.
Quarterly EBIT
-$1.34M
↑ 68.31% YoY
As of Sep 30, 2024
Annual EBIT (TTM)
-$14.16M
↑ 35.52% YoY
Trailing 12 months ending Sep 30, 2024
Biolase OverviewEBIT (Earnings Before Interest and Taxes) analysis for BIOL.
As of Sep 30, 2024
Trailing 12 months ending Sep 30, 2024